首页>
外国专利>
With its fragment or toxin subunits, or suppression of the allergic reaction by transdermal administration of allergens that are conjugated with this
With its fragment or toxin subunits, or suppression of the allergic reaction by transdermal administration of allergens that are conjugated with this
展开▼
机译:通过其片段或毒素亚基,或通过透皮给药与此结合的变应原来抑制变态反应
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention discloses the use of the non-toxic cell-binding B subunit of CT (CTB), and holotoxin CT that is devoid of ADP-ribosylating activity, as adjuvants for enhancing transcutaneous immune response to a co-administered protein allergen. It was found that topical administration of CTB to mice induced serum antibody response against itself comparable to those evoked by CT, but was inefficient at promoting systemic antibody responses against an admixed prototype protein allergen. To the contrary co-administration of either CT or CTB with allergen led to vigorous antigen-specific T cell proliferative responses in lymph nodes draining the cutaneous site of administration and at distant systemic sites. Consistent with these observations, it was found that CTB selectively potentiated Th1-driven responses without affecting Th2-dependent responses. Cutaneously applied CT enhanced serum IgE responses to a co-administered allergen, while CTB partially suppressed epicutaneously induced IgE responses to the same allergen.
展开▼